+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Chondroitin"

Osteoarthritis Therapeutics Market Report and Forecast 2024-2032 - Product Thumbnail Image

Osteoarthritis Therapeutics Market Report and Forecast 2024-2032

  • Report
  • September 2023
  • 200 Pages
  • Global
From
Plumb's Veterinary Drug Handbook. Edition No. 10 - Product Thumbnail Image

Plumb's Veterinary Drug Handbook. Edition No. 10

  • Book
  • July 2023
  • 1568 Pages
  • 2 Results (Page 1 of 1)
Loading Indicator

The Chondroitin market is a segment of the Musculoskeletal Disorders Drugs industry. Chondroitin is a naturally occurring substance found in the cartilage of animals and humans. It is used to treat a variety of musculoskeletal disorders, including osteoarthritis, rheumatoid arthritis, and other joint and bone diseases. Chondroitin is available in both oral and topical forms, and is often combined with other drugs to increase its effectiveness. Chondroitin is widely used in the treatment of musculoskeletal disorders, and its popularity is increasing due to its effectiveness and safety. It is also used in combination with other drugs to treat a variety of conditions, including osteoarthritis, rheumatoid arthritis, and other joint and bone diseases. The Chondroitin market is highly competitive, with many companies offering products in the market. Some of the major players in the market include GlaxoSmithKline, Merck, Pfizer, Sanofi, and Novartis. Other companies in the market include Allergan, AstraZeneca, and Bayer. Show Less Read more